Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

BioScience Health Innovations (BHIC) Operating Expenses (2020 - 2025)

BioScience Health Innovations (BHIC) has disclosed Operating Expenses for 6 consecutive years, with $728532.0 as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 121.4% to $728532.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 106.37% year-over-year, with the annual reading at $2.5 million for FY2025, 106.37% up from the prior year.
  • Operating Expenses for Q4 2025 was $728532.0 at BioScience Health Innovations, up from $707013.0 in the prior quarter.
  • The five-year high for Operating Expenses was $728532.0 in Q4 2025, with the low at $3209.0 in Q2 2021.
  • Average Operating Expenses over 5 years is $242980.2, with a median of $217485.0 recorded in 2023.
  • The sharpest move saw Operating Expenses grew 12.16% in 2021, then soared 1392.18% in 2022.
  • Over 5 years, Operating Expenses stood at $14089.0 in 2021, then skyrocketed by 105.25% to $28917.0 in 2022, then surged by 850.61% to $274887.0 in 2023, then grew by 19.7% to $329052.0 in 2024, then surged by 121.4% to $728532.0 in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $728532.0, $707013.0, and $616774.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.